Treatment of Cystitis in Patients with CKD and Allergies to PCN and Sulfa Antibiotics

First-Line Options

The American College of Physicians recommends nitrofurantoin (100 mg twice daily for 5 days) as the first-line treatment option for patients with cystitis who have chronic kidney disease and allergies to penicillin and sulfa antibiotics, provided renal function is adequate (eGFR >30 ml/min) 1
Fosfomycin trometamol (3 g single dose) is an appropriate alternative when nitrofurantoin is contraindicated, though it may have slightly inferior efficacy compared to standard short-course regimens, as suggested by the Infectious Diseases Society of America 2, 1

Nitrofurantoin should be avoided in patients with CKD when eGFR is <30 ml/min due to reduced efficacy and increased risk of toxicity, according to the National Kidney Foundation 1
If the patient's eGFR is <30 ml/min, fosfomycin becomes the preferred option, as recommended by the American College of Physicians 1
Urine culture with susceptibility testing is strongly recommended before initiating therapy in CKD patients to guide appropriate antibiotic selection, as advised by the Infectious Diseases Society of America 3

Fluoroquinolones (ciprofloxacin 500 mg twice daily for 7 days) may be considered when first-line agents cannot be used, despite concerns about promoting resistance, as noted by the Centers for Disease Control and Prevention 1, 3
Oral β-lactams such as cefdinir, cefaclor, or cefpodoxime-proxetil can be used for 3-7 days when other recommended agents cannot be used, but they generally have inferior efficacy, according to the American Academy of Family Physicians 2

Assess renal function: if eGFR >30 ml/min, nitrofurantoin 100 mg twice daily for 5 days is recommended; if eGFR <30 ml/min, fosfomycin trometamol 3 g single dose is preferred, as suggested by the National Kidney Foundation 1

Using nitrofurantoin in patients with severely impaired renal function (eGFR <30 ml/min) can lead to treatment failure and increased toxicity, as warned by the American College of Physicians 1
Failing to adjust antibiotic dosing based on the degree of renal impairment can lead to treatment failure or increased toxicity, as advised by the Infectious Diseases Society of America 3
Not obtaining urine cultures in patients with CKD is essential for guiding therapy in this complicated population, as recommended by the National Kidney Foundation 3

Fosfomycin trometamol 3 g as a single oral dose provides adequate urinary concentrations without requiring dose adjustment for renal impairment, with clinical cure rates of 90-91% and microbiologic cure rates of 78-80% 4
The single 3-gram dose of fosfomycin is effective in patients with eGFR <60 mL/min, resulting in only 16.0% clinical failures compared to 23.3% with nitrofurantoin 4

Patients with a documented penicillin allergy, such as a rash, should avoid cephalosporins without formal allergy testing due to cross-reactivity concerns, although the cross-reactivity rate is lower (2-4%) than historically believed 5
Cephalexin and other cephalosporins are not recommended as alternatives for penicillin-allergic patients in the treatment of active infection without formal allergy evaluation 5

In adult patients with acute uncomplicated cystitis, an eGFR > 30 mL/min, and multiple antibiotic allergies, nitrofurantoin 100 mg orally twice daily for 5 days provides a clinical cure rate of ≈ 90‑93 % and is endorsed as first‑line therapy by the Infectious Diseases Society of America (IDSA) 6.

When renal function is impaired (eGFR < 30 mL/min) or nitrofurantoin cannot be used, a single oral dose of fosfomycin trometamol 3 g achieves cure rates of ≈ 90‑91 % and is considered an appropriate first‑line alternative 6.

Trimethoprim‑sulfamethoxazole (Bactrim) and all sulfonamides should be avoided in patients with sulfa allergy 6.
Fluoroquinolones (ciprofloxacin, levofloxacin) are contraindicated in patients with documented fluoroquinolone allergy 6.
Amoxicillin‑clavulanate (Augmentin) is contraindicated in patients with a documented penicillin‑type allergy 6.
Doxycycline is both contraindicated by documented allergy and not recommended for cystitis 6.
Cefaclor (a second‑generation cephalosporin) is contraindicated in patients with a documented cephalosporin allergy 6.

Oral cephalosporins such as cefdinir, cefpodoxime‑proxetil, or cephalexin may be considered only after nitrofurantoin and fosfomycin are ruled out; however, cross‑reactivity with a known cefaclor allergy is possible, and these agents have lower cure rates and higher adverse‑event profiles compared with nitrofurantoin or fosfomycin 6.
Formal allergy testing and specialist consultation are recommended before prescribing any oral cephalosporin in this context 6.

Verify renal function (eGFR) before initiating nitrofurantoin; an eGFR < 30 mL/min is an absolute contraindication 6.
Obtain a urine culture with susceptibility testing given the complex allergy profile to ensure appropriate antibiotic selection 6.
Re‑evaluate the patient 2–3 days after therapy initiation; lack of symptom improvement may indicate resistance or an alternative diagnosis 6.

Do not prescribe amoxicillin or ampicillin empirically because of globally high resistance rates and poor efficacy for uncomplicated cystitis 6.
Do not extend nitrofurantoin therapy beyond 7 days or use it in patients with eGFR < 30 mL/min, as this raises toxicity risk without improving outcomes 6.
Do not assume all reported “allergies” are IgE‑mediated; many are intolerances that may not preclude future use, but formal assessment is advisable 6.